Key Highlights: Implications: Survey hands GSK potent ammo to ignite shingles vaccination drives targeting CKD/diabetes clinics where patient disruption peaks. Chronic disease n...
Key Highlights: Implications: Zydus’ smart-pen assault smashes generic pricing barriers, handing endocrinologists flexible dosing that trumps competitor pens while exploding Tier-2 a...
Key Highlights: Implications: Semaglutide generics could slash Novo Nordisk pricing by 70-80% in India’s $2.5B diabetes market (12% CAGR), capturing 25%+ share and pressuring chronic...
Key Highlights: Implications: Anyra smashes Eylea pricing barriers, flooding retina clinics with budget-friendly therapy that keeps patients compliant for years. Zydus seizes op...
Emerging Technology Trends in Biopharma The intersection of technology and biopharma isn’t a futuristic idea anymore it’s happening right now. Artificial intelligence (...
Key Highlights: Implications: PEPAIR smashes cost barriers to OPEP therapy, handing pulmonologists a game-changing tool that slots perfectly alongside Zydus inhalers and Deriphyllin....
